Diffuse Large B-Cell Lymphoma (DLBCL) Clinical Trials in Suzhou, Jiangsu
4 recruitingSuzhou, Jiangsu, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation
Diffuse Large B-Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University35 enrolled1 locationNCT07499271
Recruiting
Phase 2
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD.150 enrolled41 locationsNCT07189065
Recruiting
Phase 1Phase 2
A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.97 enrolled21 locationsNCT07124936
Recruiting
Phase 2
Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL
Diffuse Large B-Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University40 enrolled1 locationNCT06682130